Exelixis, Inc. (EXEL)
NASDAQ·Healthcare·Biotechnology
$56.03
+0.52%
Mkt Cap $13.92B
Analyst Ratings
Buy
5
Hold
14
Sell
0
Price Target (57 analysts)
$50.00
Range $44.00 – $56.00
Implied Upside
-10.8%
Consensus $50.00 vs current $56.03
NASDAQ·Healthcare·Biotechnology
$56.03
+0.52%
Mkt Cap $13.92B
Buy
5
Hold
14
Sell
0
Price Target (57 analysts)
$50.00
Range $44.00 – $56.00
-10.8%
Consensus $50.00 vs current $56.03